Melsmon is an injectable human placenta extract. Each 2ml ampoule contains 100mg of placenta extract, prepared from frozen fresh placenta by a dedicated method, and carries amino acids, nucleic acid substances, minerals and growth factors. A long-established placenta preparation first approved in 1956, it is indicated for the relief of menopausal symptoms and for poor lactation after childbirth, and is given by subcutaneous injection under professional supervision. This listing is the Korean version (green box) and ships from Korea.
What is Melsmon?+
Melsmon is an injectable human placenta extract that has been in clinical use since its approval in 1956. It is given by subcutaneous injection and is recognized for the relief of menopausal symptoms and for support of poor lactation after childbirth. It is a prescription product for professional use.
What does “100mg per 2ml” mean?+
Each single 2ml ampoule contains 100mg of human placenta extract as its active. The extract is prepared from frozen fresh placenta by a dedicated method, which is characteristic of how Melsmon is produced.
What does the placenta extract contain?+
It contains a range of amino acids and nucleic acid substances, minerals and growth factors among its recognized components – the substances naturally present in placenta. The activity is associated with the whole extract rather than any single isolated compound.
What is it used for?+
Its recognized indications are the relief of various menopausal disorder symptoms and support for poor lactation after childbirth. The decision to use it, and patient suitability, are determined by the treating professional.
Who should administer it?+
As a human-derived prescription product, Melsmon must be administered only by licensed medical professionals, not self-administered. It should be avoided in pregnancy, breastfeeding and in anyone with known hypersensitivity to its components. Patient suitability is assessed by the treating professional.
Melsmon is a human-derived prescription injectable for administration by licensed medical professionals only; not for self-administration. It is given by subcutaneous injection. Contraindicated in known hypersensitivity to placenta extract or any component; use in pregnancy or breastfeeding only as directed by a physician. Patient suitability must be assessed by the treating professional. Possible injection-site reactions include pain or redness.
Regulatory Notice: Approval and prescription status of human placenta preparations vary by jurisdiction and are restricted in many countries. Buyers are responsible for verifying applicable local regulations and licensing prior to import and use. FillersFairy is a distributor and not liable for clinical outcomes. Informational content only – not medical advice.

Reviews
There are no reviews yet.